RetractedArticleCurrent pharmaceutical biotechnology2011

Synthetic LXR agonist suppresses endogenous cholesterol biosynthesis and efficiently lowers plasma cholesterol.

Thomas Pfeifer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.